Publications by authors named "Ananda Bagchi"

History And Examination: A 21-year-old female patient presented to us with severe low back pain for 4 months. On examination, patient was afebrile, with severe pallor, and tenderness in both sacroiliac (SI) joints. Patient was being admitted and evaluated, and during the course of evaluation, developed severe headache, which was severe in intensity and associated with nausea and projectile vomiting.

View Article and Find Full Text PDF

Objective: The aim of this study was to evaluate the efficacy and tolerability of a new fixed-dose combination (FDC) of telmisartan 40 mg + amlodipine 5 mg (T+A) compared with amlodipine 5-mg monotherapy (A) in adult Indian patients with stage II hypertension.

Methods: This comparative, Phase III, 12-week, multicenter, prospective, randomized, double-blind study was conducted in Indian patients aged 18 to 65 years with established stage II hypertension. Patients were treated with oral FDC of T+A or A QD before breakfast for 12 weeks; blood pressure (BP) and heart rate were measured in the sitting position.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ananda Bagchi"

  • - Ananda Bagchi's recent research emphasizes the intricate relationship between autoimmune disorders and complications such as pancytopenia and disseminated intravascular coagulation, as highlighted in a case study of a young female patient presenting with multiple symptoms.
  • - Another significant area of Bagchi’s work involves evaluating the efficacy and tolerability of a fixed-dose combination treatment for stage II hypertension, demonstrating the benefits of telmisartan and amlodipine compared to amlodipine monotherapy in an Indian adult population.
  • - Throughout his research, Bagchi combines clinical assessments with well-designed studies to address complex medical conditions, aiming to improve patient outcomes through tailored therapeutic approaches.